-
Something wrong with this record ?
Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer
P. Vychytilova-Faltejskova, L. Radova, M. Sachlova, Z. Kosarova, K. Slaba, P. Fabian, T. Grolich, V. Prochazka, Z. Kala, M. Svoboda, I. Kiss, R. Vyzula, O. Slaby,
Language English Country England, Great Britain
Document type Journal Article
Grant support
NT13549
MZ0
CEP Register
NLK
Free Medical Journals
from 1996 to 1 year ago
Open Access Digital Library
from 1996-01-01
Medline Complete (EBSCOhost)
from 1996-01-01 to 1 year ago
PubMed
27485599
DOI
10.1093/carcin/bgw078
Knihovny.cz E-resources
- MeSH
- Early Detection of Cancer MeSH
- Middle Aged MeSH
- Humans MeSH
- MicroRNAs blood MeSH
- Biomarkers, Tumor blood MeSH
- Colonic Neoplasms blood genetics pathology MeSH
- Prognosis MeSH
- Gene Expression Regulation, Neoplastic MeSH
- Aged MeSH
- Neoplasm Staging MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
Early detection of colorectal cancer is the main prerequisite for successful treatment and reduction of mortality. Circulating microRNAs were previously identified as promising diagnostic, prognostic and predictive biomarkers. The purpose of this study was to identify serum microRNAs enabling early diagnosis and prognosis prediction of colon cancer. In total, serum samples from 427 colon cancer patients and 276 healthy donors were included in three-phase biomarker study. Large-scale microRNA expression profiling was performed using Illumina small RNA sequencing. Diagnostic and prognostic potential of identified microRNAs was validated on independent training and validation sets of samples using RT-qPCR. Fifty-four microRNAs were found to be significantly deregulated in serum of colon cancer patients compared to healthy donors (P < 0.01). A diagnostic four-microRNA signature consisting of miR-23a-3p, miR-27a-3p, miR-142-5p and miR-376c-3p was established (AUC = 0.917), distinguishing colon cancer patients from healthy donors with sensitivity of 89% and specificity of 81% (AUC = 0.922). This panel of microRNAs exhibited high diagnostic performance also when analyzed separately in colon cancer patients in early stages of the disease (T1-4N0M0; AUC = 0.877). Further, a prognostic panel based on the expression of miR-23a-3p and miR-376c-3p independent of TNM stage was established (HR 2.30; 95% CI 1.44-3.66; P < 0.0004). In summary, highly sensitive signatures of circulating microRNAs enabling non-invasive early detection and prognosis prediction of colon cancer were identified.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17023813
- 003
- CZ-PrNML
- 005
- 20191011091519.0
- 007
- ta
- 008
- 170720s2016 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/carcin/bgw078 $2 doi
- 035 __
- $a (PubMed)27485599
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Vychytilová, Petra, $u Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic. Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk Memorial Cancer Institute, Masaryk University, Zluty kopec 7, 656 53 Brno, Czech Republic and. $d 1987- $7 xx0165184
- 245 10
- $a Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer / $c P. Vychytilova-Faltejskova, L. Radova, M. Sachlova, Z. Kosarova, K. Slaba, P. Fabian, T. Grolich, V. Prochazka, Z. Kala, M. Svoboda, I. Kiss, R. Vyzula, O. Slaby,
- 520 9_
- $a Early detection of colorectal cancer is the main prerequisite for successful treatment and reduction of mortality. Circulating microRNAs were previously identified as promising diagnostic, prognostic and predictive biomarkers. The purpose of this study was to identify serum microRNAs enabling early diagnosis and prognosis prediction of colon cancer. In total, serum samples from 427 colon cancer patients and 276 healthy donors were included in three-phase biomarker study. Large-scale microRNA expression profiling was performed using Illumina small RNA sequencing. Diagnostic and prognostic potential of identified microRNAs was validated on independent training and validation sets of samples using RT-qPCR. Fifty-four microRNAs were found to be significantly deregulated in serum of colon cancer patients compared to healthy donors (P < 0.01). A diagnostic four-microRNA signature consisting of miR-23a-3p, miR-27a-3p, miR-142-5p and miR-376c-3p was established (AUC = 0.917), distinguishing colon cancer patients from healthy donors with sensitivity of 89% and specificity of 81% (AUC = 0.922). This panel of microRNAs exhibited high diagnostic performance also when analyzed separately in colon cancer patients in early stages of the disease (T1-4N0M0; AUC = 0.877). Further, a prognostic panel based on the expression of miR-23a-3p and miR-376c-3p independent of TNM stage was established (HR 2.30; 95% CI 1.44-3.66; P < 0.0004). In summary, highly sensitive signatures of circulating microRNAs enabling non-invasive early detection and prognosis prediction of colon cancer were identified.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a nádorové biomarkery $x krev $7 D014408
- 650 _2
- $a nádory tračníku $x krev $x genetika $x patologie $7 D003110
- 650 _2
- $a časná detekce nádoru $7 D055088
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a regulace genové exprese u nádorů $7 D015972
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mikro RNA $x krev $7 D035683
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a staging nádorů $7 D009367
- 650 _2
- $a prognóza $7 D011379
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Radova, Lenka $u Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic.
- 700 1_
- $a Šachlová, Milana, $u Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk Memorial Cancer Institute, Masaryk University, Zluty kopec 7, 656 53 Brno, Czech Republic and. $d 1959- $7 mzk2006322883
- 700 1_
- $a Kosařová, Zdeňka $u Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic. $7 xx0238154
- 700 1_
- $a Slaba, Katerina $u Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic.
- 700 1_
- $a Fabian, Pavel $u Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk Memorial Cancer Institute, Masaryk University, Zluty kopec 7, 656 53 Brno, Czech Republic and. $7 xx0041823
- 700 1_
- $a Grolich, Tomáš $u Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic. Department of Surgery, Institutions Shared with the Faculty Hospital Brno, Faculty of Medicine, Masaryk University, Jihlavska 340/20, 625 00 Brno, Czech Republic. $7 xx0228879
- 700 1_
- $a Procházka, Vladimír, $u Department of Surgery, Institutions Shared with the Faculty Hospital Brno, Faculty of Medicine, Masaryk University, Jihlavska 340/20, 625 00 Brno, Czech Republic. $d 1972- $7 xx0070644
- 700 1_
- $a Kala, Zdeněk, $u Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic. Department of Surgery, Institutions Shared with the Faculty Hospital Brno, Faculty of Medicine, Masaryk University, Jihlavska 340/20, 625 00 Brno, Czech Republic. $d 1960- $7 xx0003702
- 700 1_
- $a Svoboda, Marek, $u Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic. Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk Memorial Cancer Institute, Masaryk University, Zluty kopec 7, 656 53 Brno, Czech Republic and. $d 1975- $7 xx0098478
- 700 1_
- $a Kiss, Igor, $u Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk Memorial Cancer Institute, Masaryk University, Zluty kopec 7, 656 53 Brno, Czech Republic and. $d 1965- $7 xx0031864
- 700 1_
- $a Vyzula, Rostislav, $u Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk Memorial Cancer Institute, Masaryk University, Zluty kopec 7, 656 53 Brno, Czech Republic and. $d 1952- $7 nlk20000083661
- 700 1_
- $a Slabý, Ondřej, $u Centre for Molecular Medicine, Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic. Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk Memorial Cancer Institute, Masaryk University, Zluty kopec 7, 656 53 Brno, Czech Republic and. $d 1981- $7 js20030220015
- 773 0_
- $w MED00001050 $t Carcinogenesis $x 1460-2180 $g Roč. 37, č. 10 (2016), s. 941-950
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27485599 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20191011091939 $b ABA008
- 999 __
- $a ok $b bmc $g 1239494 $s 984726
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 37 $c 10 $d 941-950 $e 20160801 $i 1460-2180 $m Carcinogenesis $n Carcinogenesis $x MED00001050
- GRA __
- $a NT13549 $p MZ0
- LZP __
- $a Pubmed-20170720